Hsbc Holdings PLC Sells 26,843 Shares of Pediatrix Medical Group, Inc. $MD

Hsbc Holdings PLC lowered its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 23.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 88,822 shares of the company’s stock after selling 26,843 shares during the period. Hsbc Holdings PLC’s holdings in Pediatrix Medical Group were worth $1,890,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Global Retirement Partners LLC raised its position in Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after purchasing an additional 1,365 shares during the period. Transamerica Financial Advisors LLC purchased a new position in shares of Pediatrix Medical Group in the 4th quarter worth approximately $30,000. Eurizon Capital SGR S.p.A. purchased a new position in shares of Pediatrix Medical Group in the 4th quarter worth approximately $33,000. Blue Trust Inc. bought a new position in shares of Pediatrix Medical Group during the 4th quarter valued at approximately $37,000. Finally, TD Private Client Wealth LLC bought a new position in shares of Pediatrix Medical Group during the 4th quarter valued at approximately $39,000. 97.71% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on MD shares. Jefferies Financial Group restated a “buy” rating and issued a $27.00 price target on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Mizuho set a $24.00 price target on Pediatrix Medical Group in a research note on Friday, May 8th. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Wednesday, June 24th. Truist Financial boosted their price objective on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Finally, UBS Group upped their price objective on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $23.33.

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD opened at $26.25 on Monday. The firm has a 50 day moving average of $24.17 and a 200 day moving average of $22.34. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $2.16 billion, a price-to-earnings ratio of 12.74 and a beta of 0.66. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $27.94.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The business had revenue of $476.20 million for the quarter, compared to analysts’ expectations of $465.83 million. During the same quarter last year, the firm earned $0.33 EPS. The business’s revenue for the quarter was up 3.9% on a year-over-year basis. On average, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 2.1 earnings per share for the current fiscal year.

Insider Buying and Selling at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 36,028 shares of the company’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total transaction of $855,665.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.80% of the stock is owned by company insiders.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.